Abivax (AAVXF) Intangibles (2021 - 2026)

Abivax has reported Intangibles for 6 years, with the latest figure at $7.7 million in Q1 2026.

• On a quarterly basis, Intangibles rose 11.28% year-over-year to $7.7 million in Q1 2026; TTM through Mar 2026 was $7.7 million, a 11.28% increase from a year earlier, with the FY2025 full-year figure at $7.7 million, up 8.92% from the prior year.
• Intangibles was $7.7 million for Q1 2026 at Abivax, up from $7.7 million in the prior quarter.
• The five-year high for Intangibles was $7.7 million in Q1 2026, with the low at $6.7 million in Q4 2022.
• Average Intangibles over 5 years is $7.3 million, with a median of $7.1 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Intangibles surged 6235.95% in 2022, then retreated 0.65% in 2024.
• Over 5 years, Intangibles stood at $6.7 million in 2022, then advanced by 5.41% to $7.1 million in 2023, then declined by 0.65% to $7.1 million in 2024, then grew by 8.92% to $7.7 million in 2025, then gained by 0.58% to $7.7 million in 2026.
• The last three Intangibles figures came in at $7.7 million (Q1 2026), $7.7 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.